Publication | Open Access
Prothymosin α overexpression contributes to the development of pulmonary emphysema
39
Citations
48
References
2013
Year
Lung InflammationImmunologyPulmonary EmphysemaPulmonary Alveolar ProteinosisEmphysema PatientsSmoking Related Lung DiseaseCell SignalingEmphysema RemainsPulmonary CirculationAllergyPulmonary FibrosisPulmonary MedicineEpigenetic RegulationCell BiologyLung CancerPulmonary DiseaseMolecular MedicineEmphysema PhenotypePhysiologyPulmonary PhysiologyLung MechanicsMedicine
Emphysema is one of the disease conditions that comprise chronic obstructive pulmonary disease. Prothymosin α transgenic mice exhibit an emphysema phenotype, but the pathophysiological role of prothymosin α in emphysema remains unclear. Here we show that prothymosin α contributes to the pathogenesis of emphysema by increasing acetylation of histones and nuclear factor-kappaB, particularly upon cigarette smoke exposure. We find a positive correlation between prothymosin α levels and the severity of emphysema in prothymosin α transgenic mice and emphysema patients. Prothymosin α overexpression increases susceptibility to cigarette smoke-induced emphysema, and cigarette smoke exposure further enhances prothymosin α expression. We show that prothymosin α inhibits the association of histone deacetylases with histones and nuclear factor-kappaB, and that prothymosin α overexpression increases expression of nuclear factor-kappaB-dependent matrix metalloproteinase 2 and matrix metalloproteinase 9, which are found in the lungs of patients with chronic obstructive pulmonary disease. These results demonstrate the clinical relevance of prothymosin α in regulating acetylation events during the pathogenesis of emphysema.
| Year | Citations | |
|---|---|---|
Page 1
Page 1